Trastuzumab Deruxtecan Slows Metastatic Breast Cancer
Progression-free survival longer with T-DXd versus T-DM1 for HER2+ metastatic breast cancer previously treated with trastuzumab and taxane
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.